Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pamprin CRPs

This article was originally published in The Tan Sheet

Executive Summary

Chattem submits to an administrative law judge June 15 a timetable to place 16 and 24-count packages of its menstrual pain product in child-resistant containers. "Following a program of consumer research," the company said, products in new packaging will ship to trade in April 1995, June 1995 or another date depending on which of three packaging options -- bottle, blister or pouch -- is chosen by August. The Consumer Product Safety Commission took Chattem to court in February, alleging the company violated the Poison Prevention Packaging Act by failing to market Pamprin with CRPs in "popular-size packages." An administrative judge ordered Chattem in March to submit a repackaging plan ("The Tan Sheet" March 28, p. 6)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel